Details for New Drug Application (NDA): 085186
✉ Email this page to a colleague
NDA 085186 describes ELIXOPHYLLIN, which is a drug marketed by Forest Labs and Solis Pharms and is included in four NDAs. Additional details are available on the ELIXOPHYLLIN profile page.
The generic ingredient in ELIXOPHYLLIN is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in ELIXOPHYLLIN is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 085186
| Tradename: | ELIXOPHYLLIN |
| Applicant: | Solis Pharms |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085186
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION, ELIXIR;ORAL | Strength | 80MG/15ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
